Fresh2 Group Limited (FRES)

0,4135 -0,0175 (-4,06%) Börsenschluss: 04:00PM EDT

Fresh2 Group Limited

650 5th Ave
Suite 2416
New York, NY 10019-6108
United States

https://fresh2.co

Sektor(en): Healthcare
Branche: Biotechnology
Vollzeitmitarbeiter: 75

Leitende Angestellte

Name	Titel	Zahlen	Ausgeübt	Geburtsjahr
Mr. Haohan Xu	Chairman of the Board & CEO	N/A	N/A	1995
Dr. He Yu	Co-Founder & Chief Scientist	N/A	N/A	1958
Ms. Xiaoyu Li	Director & CFO	N/A	N/A	1989
Mr. Weidong Dai	China President	N/A	N/A	1961
Dr. Sunil Pandit	U.S. Chief Executive Officer	N/A	N/A	N/A
Mr. Yidong Hu	Chief Strategy Officer	N/A	N/A	N/A

Die Beträge haben den Stand und Kompensationswerte gelten für das letzte Geschäftsjahr bis zu diesem Datum. Der Lohn umfasst Gehalt, Boni usw. „Ausgeübt“ entspricht dem Wert von Optionen, die im Lauf des Geschäftsjahrs ausgeübt werden. Währung in USD.

Beschreibung

Fresh2 Group Limited, a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup packages, as well as technology services comprising market research, designing, coding, developing, testing, etc. In addition, the company sells genetic testing kits and skin-care products; and owns core technology platforms, as well as engages in technology development and product distribution. Further, it operates an e-commerce platform that connects food suppliers and supermarket operators and restaurant owners. The company was formerly known as AnPac Bio-Medical Science Co., Ltd. and changed its name to Fresh2 Group Limited in April 2023. The company was incorporated in 2010 and is based in New York, New York.

Corporate Governance

Fresh2 Group Limiteds ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.

Corporate-Governance-Bewertungen von Institutional Shareholder Services (ISS). Die Werte geben den Zehntelwert im Verhältnis zum Index oder zur Region an. Ein Zehntelwert von 1 zeigt geringeres Governance-Risiko, 10 höheres Governance-Risiko.